Artículos de revistas
The Carmaphycins: New Proteasome Inhibitors Exhibiting an alpha,beta-Epoxyketone Warhead from a Marine Cyanobacterium
Fecha
2012Registro en:
CHEMBIOCHEM, WEINHEIM, v. 13, n. 6, p. 810-817, APR. 2012
1439-4227
10.1002/cbic.201200007
Autor
Pereira, Alban R.
Kale, Andrew J.
Fenley, Andrew T.
Byrum, Tara
Debonsi, Hosana M.
Gilson, Michael K.
Valeriote, Frederick A.
Moore, Bradley S.
Gerwick, William H.
Institución
Resumen
Two new peptidic proteasome inhibitors were isolated as trace components from a Curacao collection of the marine cyanobacterium Symploca sp. Carmaphycin A (1) and carmaphycin B (2) feature a leucine-derived a,beta-epoxyketone warhead directly connected to either methionine sulfoxide or methionine sulfone. Their structures were elucidated on the basis of extensive NMR and MS analyses and confirmed by total synthesis, which in turn provided more material for further biological evaluations. Pure carmaphycins A and B were found to inhibit the beta 5 subunit (chymotrypsin-like activity) of the S. cerevisiae 20S proteasome in the low nanomolar range. Additionally, they exhibited strong cytotoxicity to lung and colon cancer cell lines, as well as exquisite antiproliferative effects in the NCI60 cell-line panel. These assay results as well as initial structural biology studies suggest a distinctive binding mode for these new inhibitors.